| Ticker Details |
Bristol-Myers Squibb Co.
Bristol-Myers Squibb Co is engaged in discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceuticals products. The company operates in one segment that is Biopharmaceuticals.
|
| IPO Date: |
December 31, 1981 |
| Sector: |
Healthcare |
| Industry: |
Pharma |
| Market Cap: |
$123.53B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.41 | 0.93%
|
| Avg Daily Range (30 D): |
$0.50 | 0.87%
|
| Avg Daily Range (90 D): |
$0.49 | 0.96%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
9.43M |
| Avg Daily Volume (30 D): |
9.93M |
| Avg Daily Volume (90 D): |
11.24M |
| Trade Size |
| Avg Trade Size (Sh.): |
178 |
| Avg Trade Size (Sh.) (30 D): |
89 |
| Avg Trade Size (Sh.) (90 D): |
100 |
| Institutional Trades |
| Total Institutional Trades: |
128,219 |
| Avg Institutional Trade: |
$5.08M |
| Avg Institutional Trade (30 D): |
$7.25M |
| Avg Institutional Trade (90 D): |
$7.86M |
| Avg Institutional Trade Volume: |
.11M |
| Avg Institutional Trades (Per Day): |
22 |
| Market Closing Trades |
| Avg Closing Trade: |
$56.92M |
| Avg Closing Trade (30 D): |
$116.36M |
| Avg Closing Trade (90 D): |
$117.24M |
| Avg Closing Volume: |
1.07M |
|
|
| Financials |
| |
TTM |
Q4 2025 |
FY 2025 |
|
Basic EPS
|
$3.47
|
$.54
|
$3.47
|
|
Diluted EPS
|
$3.46
|
$.53
|
$3.46
|
|
Revenue
|
$48.19B
|
$12.5B
|
$48.19B
|
|
Gross Profit
|
$34.26B
|
$8.41B
|
$34.26B
|
|
Net Income / Loss
|
$7.06B
|
$1.09B
|
$7.06B
|
|
Operating Income / Loss
|
$9.33B
|
$1.47B
|
$9.33B
|
|
Cost of Revenue
|
$13.94B
|
$4.1B
|
$13.94B
|
|
Net Cash Flow
|
$-129M
|
$-5508M
|
$-129M
|
|
PE Ratio
|
17.80
|
|
|
|
|
|
